SUN-753 Three-Year Evolution of X-Linked Hypophosphatemia in Children Treated with Burosumab: Predictive Factors for Dosing and Long-Term Outcomes

J Endocr Soc · 2025 · PMC12545477

Europe PMC

hedged sentences

0.0603

closest p · 1.2× alpha

0.0603

boldest claim

The sentences

a trend toward significancep = 0.0603so close (0.05 < p ≤ 0.1)

ALP showed a trend toward significance ( p = 0.0603).

also in 2,500 other papers

showed a trendp = 0.0603so close (0.05 < p ≤ 0.1)

ALP showed a trend toward significance ( p = 0.0603).

also in 33,237 other papers

a decreasing trendno p-value reported

Additionally, long-term complications, such as nephrocalcinosis and hearing loss, showed a decreasing trend, suggesting the potential protective effects of burosumab.

also in 29,529 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.